OraSure Technologies traded at $3.15 this Friday February 27th, increasing $0.07 or 2.27 percent since the previous trading session. Looking back, over the last four weeks, OraSure Technologies gained 16.67 percent. Over the last 12 months, its price fell by 9.48 percent. Looking ahead, we forecast OraSure Technologies to be priced at 2.66 by the end of this quarter and at 2.42 in one year, according to Trading Economics global macro models projections and analysts expectations.
OraSure Technologies, Inc. (OraSure) is a medical device company that develops, manufactures, and markets medical devices and diagnostic products. The Company's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.